FDA limits use of Regeneron and Lilly COVID antibody treatments

Argentina Noticias Noticias

FDA limits use of Regeneron and Lilly COVID antibody treatments
Argentina Últimas Noticias,Argentina Titulares
  • 📰 axios
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

The FDA said 'data show these treatments are highly unlikely to be active' against Omicron.

Photo: Anna Moneymaker/Getty Images

Defense Secretary Lloyd Austin has placed 8,500 U.S. troops on "heightened preparedness to deploy" to eastern Europe in case NATO activates itsNo decisions have been made to actually deploy U.S. forces, but the heightened alert level will allow the military to rapidly shore up NATO's eastern flank in the event that Russia invades Ukraine. The Pentagon warned that Russia has shown "no signs of de-escalating," and continues to amass troops on Ukraine's borders.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

axios /  🏆 302. in US

Argentina Últimas Noticias, Argentina Titulares



Render Time: 2025-04-02 15:41:48